Asset profile
zopapogene imadenovec-drba · Precigen (PGEN)
- Indication
- recurrent respiratory papillomatosis (RRP) in adults
- Also known as
- PAPZIMEOS
Company
PGENPrecigen
PGENPrecigenPrecigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology…
On the calendar
Nothing scheduled in this window.
Timeline
Newest first.
More from Precigen
Other drugs and candidates from the same company tracked in this sector.